146 related articles for article (PubMed ID: 20061922)
1. ATP-binding cassette subfamily B member 1 polymorphisms do not determine cyclosporin exposure, acute rejection or nephrotoxicity after heart transplantation.
Taegtmeyer AB; Breen JB; Smith J; Burke M; Leaver N; Pantelidis P; Lyster H; Yacoub MH; Barton PJ; Banner NR
Transplantation; 2010 Jan; 89(1):75-82. PubMed ID: 20061922
[TBL] [Abstract][Full Text] [Related]
2. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
Zhang Y; Li JL; Fu Q; Wang XD; Liu LS; Wang CX; Xie W; Chen ZJ; Shu WY; Huang M
Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
Bouamar R; Hesselink DA; van Schaik RH; Weimar W; Macphee IA; de Fijter JW; van Gelder T
Ther Drug Monit; 2011 Apr; 33(2):178-84. PubMed ID: 21383650
[TBL] [Abstract][Full Text] [Related]
4. ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.
García M; Macías RM; Cubero JJ; Benítez J; Caravaca F; Gervasini G
Eur J Clin Pharmacol; 2013 Mar; 69(3):385-93. PubMed ID: 22886152
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.
Meng XG; Guo CX; Feng GQ; Zhao YC; Zhou BT; Han JL; Chen X; Shi Y; Shi HY; Yin JY; Peng XD; Pei Q; Zhang W; Wang G; He M; Liu M; Yang JK; Zhou HH
Acta Pharmacol Sin; 2012 Dec; 33(12):1563-70. PubMed ID: 23085740
[TBL] [Abstract][Full Text] [Related]
6. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
[TBL] [Abstract][Full Text] [Related]
7. Donor P-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up.
Woillard JB; Rerolle JP; Picard N; Rousseau A; Guillaudeau A; Munteanu E; Essig M; Drouet M; Le Meur Y; Marquet P
Clin Pharmacol Ther; 2010 Jul; 88(1):95-100. PubMed ID: 20505666
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients.
Zhang YT; Yang LP; Shao H; Li KX; Sun CH; Shi LW
Br J Clin Pharmacol; 2008 Aug; 66(2):240-6. PubMed ID: 18717915
[TBL] [Abstract][Full Text] [Related]
9. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.
von Ahsen N; Richter M; Grupp C; Ringe B; Oellerich M; Armstrong VW
Clin Chem; 2001 Jun; 47(6):1048-52. PubMed ID: 11375290
[TBL] [Abstract][Full Text] [Related]
10. MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients.
Bonhomme-Faivre L; Devocelle A; Saliba F; Chatled S; Maccario J; Farinotti R; Picard V
Transplantation; 2004 Jul; 78(1):21-5. PubMed ID: 15257034
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis.
Wang CE; Lu KP; Chang Z; Guo ML; Qiao HL
Gene; 2018 Jul; 664():44-49. PubMed ID: 29678659
[TBL] [Abstract][Full Text] [Related]
12. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.
Riegersperger M; Plischke M; Steinhauser C; Jallitsch-Halper A; Sengoelge G; Winkelmayer WC; Sunder-Plassmann G; Födinger M
Clin Lab; 2016 Oct; 62(10):1965-1972. PubMed ID: 28164520
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
[TBL] [Abstract][Full Text] [Related]
14. CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients.
Wang YY; Zhang M; Lu FM; Jiao Z; Qiu XY
Chin Med J (Engl); 2012 Dec; 125(23):4233-8. PubMed ID: 23217392
[TBL] [Abstract][Full Text] [Related]
15. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
Singh R; Srivastava A; Kapoor R; Mittal RD
J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
[TBL] [Abstract][Full Text] [Related]
16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
17. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
[TBL] [Abstract][Full Text] [Related]
18. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
[TBL] [Abstract][Full Text] [Related]
19. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
